122 results on '"Van den Abbeele, Pieter"'
Search Results
2. Small intestine vs. colon ecology and physiology: Why it matters in probiotic administration
3. A randomized, placebo-controlled trial investigating the acute and chronic benefits of American Ginseng (Cereboost®) on mood and cognition in healthy young adults, including in vitro investigation of gut microbiota changes as a possible mechanism of action
4. Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson's disease
5. Inclusion of small intestinal absorption and simulated mucosal surfaces further improve the Mucosal Simulator of the Canine Intestinal Microbial Ecosystem (M-SCIME™)
6. Comparative analysis of the gut microbiota cultured in vitro using a single colon versus a 3-stage colon experimental design
7. Serum-Derived Bovine Immunoglobulin Promotes Barrier Integrity and Lowers Inflammation for 24 Human Adults Ex Vivo.
8. Targeted remodeling of the human gut microbiome using Juemingzi (Senna seed extracts).
9. Tomato seed extract promotes health of the gut microbiota and demonstrates a potential new way to valorize tomato waste.
10. A 4-strain probiotic supplement influences gut microbiota composition and gut wall function in patients with ulcerative colitis
11. A synbiotic concept containing spore-forming Bacillus strains and a prebiotic fiber blend consistently enhanced metabolic activity by modulation of the gut microbiome in vitro
12. A Long-Chain Dextran Produced by Weissella cibaria Boosts the Diversity of Health-Related Gut Microbes Ex Vivo.
13. A combination of xylooligosaccharides and a polyphenol blend affect microbial composition and activity in the distal colon exerting immunomodulating properties on human cells
14. Long chain arabinoxylans shift the mucosa-associated microbiota in the proximal colon of the simulator of the human intestinal microbial ecosystem (M-SHIME)
15. Low-no-calorie sweeteners exert marked compound-specific impact on the human gut microbiota ex vivo.
16. Bridging preclinical and clinical gut microbiota research using the ex vivo SIFR® technology.
17. Carrot RG-I Reduces Interindividual Differences between 24 Adults through Consistent Effects on Gut Microbiota Composition and Function Ex Vivo.
18. HMOs Exert Marked Bifidogenic Effects on Children's Gut Microbiota Ex Vivo, Due to Age-Related Bifidobacterium Species Composition.
19. Inulin-type fructan fermentation by bifidobacteria depends on the strain rather than the species and region in the human intestine
20. Experimental models of the gut microbiome
21. Mucosa‐associated biohydrogenating microbes protect the simulated colon microbiome from stress associated with high concentrations of poly‐unsaturated fat
22. Lacticaseibacillus rhamnosus ATCC 53103 and Limosilactobacillus reuteri ATCC 53608 Synergistically Boost Butyrate Levels upon Tributyrin Administration Ex Vivo.
23. Development of a reproducible small intestinal microbiota model and its integration into the SHIME®-system, a dynamic in vitro gut model.
24. Galactooligosaccharide (GOS) Reduces Branched Short-Chain Fatty Acids, Ammonium, and pH in a Short-Term Colonic Fermentation Model.
25. Serum-Derived Bovine Immunoglobulin Stimulates SCFA Production by Specific Microbes in the Ex Vivo SIFR ® Technology.
26. Dynamic effects of probiotic formula ecologic®825 on human small intestinal ileostoma microbiota: a network theory approach.
27. Improved in vitro assay for determining the mucin adherence of bacteria sensitive to Triton X-100 treatment
28. Development of an oral mucosa model to study host-microbiome interactions during wound healing
29. Effect of encapsulated Lactobacillus casei 01 along with pressurized-purple-rice drinks on colonizing the colon in the digestive model
30. Chronic cigarette smoke exposure induces microbial and inflammatory shifts and mucin changes in the murine gut
31. Long-Term Lactulose Administration Improves Dysbiosis Induced by Antibiotic and C. difficile in the PathoGut TM SHIME Model.
32. Interindividual differences in response to treatment with butyrate-producing Butyricicoccus pullicaecorum 25–3T studied in an in vitro gut model
33. Comparative Genomics and Physiology of Akkermansia muciniphila Isolates from Human Intestine Reveal Specialized Mucosal Adaptation.
34. Co-Administration of Lactulose Crystals with Amoxicillin Followed by Prolonged Lactulose Treatment Promotes Recovery of the Human Gut Microbiome In Vitro.
35. Synthetic microbial ecosystems: an exciting tool to understand and apply microbial communities
36. In vitro model to study the modulation of the mucin-adhered bacterial community
37. Human Milk Oligosaccharides and Lactose Differentially Affect Infant Gut Microbiota and Intestinal Barrier In Vitro.
38. A Freeze-Dried Cranberry Powder Consistently Enhances SCFA Production and Lowers Abundance of Opportunistic Pathogens In Vitro.
39. impact of environmental pH on the gut microbiota community structure and short chain fatty acid production.
40. The Effect of Amino Acids on Production of SCFA and bCFA by Members of the Porcine Colonic Microbiota.
41. Intestinal colonization: How key microbial players become established in this dynamic process: Microbial metabolic activities and the interplay between the host and microbes
42. Evaluation of the Anti-Adhesive Effect of Milk Fat Globule Membrane Glycoproteins on Helicobacter pylori in the Human NCI-N87 Cell Line and C57BL/6 Mouse Model
43. Microbiotas from UC patients display altered metabolism and reduced ability of LAB to colonize mucus
44. Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats
45. Microbial fermentation of Fossence™, a short-chain fructo-oligosaccharide, under simulated human proximal colonic condition and assessment of its prebiotic effects—a pilot study.
46. A Cranberry Concentrate Decreases Adhesion and Invasion of Escherichia coli (AIEC) LF82 In Vitro.
47. In vitro evaluation of the anti-pathogenic activity of Okoubaka aubrevillei on the human gastrointestinal tract.
48. Fructans with Varying Degree of Polymerization Enhance the Selective Growth of Bifidobacterium animalis subsp. lactis BB-12 in the Human Gut Microbiome In Vitro.
49. Metabolic Analysis of Regionally Distinct Gut Microbial Communities Using an In Vitro Platform.
50. Yeast-Derived Formulations Are Differentially Fermented by the Canine and Feline Microbiome As Assessed in a Novel In Vitro Colonic Fermentation Model.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.